Impact of COVID-19 on Business Activities
First written in FY2020. 8 of 12 entries say "Restated". Latest entry: FY2024.
The whole theme swung hardest in 2025: 7 of 24 companies on the "Worse" side.
20 other companies' latest entry also says "Dropped".
- FY2024DroppedAnnual report
「During the current fiscal year, the Japanese economy continued amid volatility in raw material prices and downside risks to overseas economies due to the situation surrounding Ukraine and the Middle East and global monetary tightening, although a gradual recovery is expected to continue as employment and income conditions improve.」
In the filing's discussion of the business environment and business and other risks, the impact of COVID-19 on business activities is not identified as a standalone risk. - FY2023MitigatedAnnual report
「In the chemical equipment business, revenue increased as many customers recovered from the impact of COVID-19 and capital investment increased.」
Regarding the impact of COVID-19 on customers and capital investment, the company states that many customers have recovered and that the previous impact has eased. - FY2023-Q2RestatedAnnual report
「During the second quarter of the current fiscal year, the Japanese economy continued amid unstable raw material prices and downside risks to overseas economies resulting from the prolonged situation in Ukraine and the impact of COVID-19.」
The company continues to identify the prolonged situation in Ukraine, COVID-19, unstable raw material prices and downside risks to overseas economies. It states that there have been no material changes in business and other risks. - FY2023-Q1RestatedAnnual report
「During the first quarter of the current fiscal year, the Japanese economy continued amid concerns about the resurgence of COVID-19 and the prolonged situation in Ukraine, as well as rising raw material prices and downside risks to overseas economies, requiring close attention to these developments.」
The company continues to disclose the risk of an economic downturn resulting from a resurgence of COVID-19. It states that there have been no material changes in business and other risks. - FY2022-Q3WorsenedAnnual report
「The economy has also shown signs of recovery as vaccination progresses and overseas economies improve, but the rapid spread of infections following the emergence of the Omicron variant means that close attention must be paid to the impact of infection trends on domestic and overseas economies.」
The rapid spread of infections following the emergence of the Omicron variant is newly identified, heightening concerns about its impact on domestic and overseas economies. At the same time, the company states that the impact of the pandemic on the Group remains limited at this stage. - FY2022-Q2RestatedAnnual report
「Although the Group considers future developments in infections in Japan and overseas to be uncertain and continues to operate in an environment with no clear outlook, it believes that the impact on the Group is limited.」
While stating that developments in COVID-19 and its impact on domestic and overseas economies are uncertain, the company reconfirms its view that the impact on the Group is limited at present. - FY2022-Q1RestatedAnnual report
「During the first quarter of the current fiscal year, the Japanese economy remained in a difficult situation, affected by COVID-19 and other factors. Although the economy is expected to continue showing signs of recovery as vaccination progresses, close attention must be paid to the impact of infection trends on domestic and overseas economies.」
The company describes the difficult economic conditions caused by the pandemic and the expectation of a recovery driven by vaccinations, while continuing to caution about the impact of infection trends on domestic and overseas economies. - FY2021RestatedAnnual report
「As of the filing date, the Group has not experienced any material impact from COVID-19 or the related state of emergency, although」
While stating that no material impact from the pandemic has occurred, the company continues to disclose the possibility of business contraction due to transaction suspensions, production stoppages, temporary closures and clusters at workplaces. - FY2021-Q3RestatedAnnual report
「Although the impact of COVID-19 on the Group is limited at this stage, developments in infections in Japan and overseas remain uncertain, and the Group continues to operate in an environment with no clear outlook.」
While stating that the impact of the pandemic remains limited at present, the company continues to disclose the uncertainty surrounding infection trends in Japan and overseas and the outlook. - FY2021-Q2RestatedAnnual report
「Although the impact of COVID-19 on the Group is limited at this stage, developments in infections in Japan and overseas remain uncertain, and the Group continues to operate in an environment with no clear outlook.」
While stating that the impact of COVID-19 remains limited at present, the company reconfirms the uncertainty surrounding infection trends in Japan and overseas and the outlook. - FY2021-Q1RestatedAnnual report
「During the first quarter of the current fiscal year, the Japanese economy remained in a difficult situation as the global spread of COVID-19 placed significant restrictions on corporate and social activity. Although the economy is beginning to bottom out following the lifting of the state of emergency, close attention must continue to be paid to developments in infections in Japan and overseas and to risks that could push down domestic and overseas economies.」
The company reconfirms the restrictions on corporate and social activity caused by the pandemic and the risks of a downturn in domestic and overseas economies. It states in the business and other risks section that there have been no new risks or material changes. - FY2020First statedAnnual report
「As of the filing date, the Group has not experienced any material impact from COVID-19. However, transaction suspensions, production stoppages, temporary closures and other events may occur in the industries, markets and among business partners with which the Group is involved, potentially affecting the Group's operating results and financial position.」
While stating that no material impact had occurred as of the filing date, the company discloses the possibility of business contraction resulting from transaction suspensions, production stoppages, temporary closures and employee infections as new risks.